Fromkin Andrew J. — SEC Form 4 filings
SEC reporting owner CIK 1341896. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-29.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-04-04 to 2026-05-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 3 filings — 252,200 shares, $8,112,069 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 210,468 shares @ $33.56 ($7,063,306) in Immunovant, Inc., filed 2026-05-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | Director | 6 | — | 6 legs · 252,200 sh · $8,112,069 | 14 |
Form 4 filings — Fromkin Andrew J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-29 | 4 | Immunovant, Inc. (IMVT) | Option exercise (M): 31,668 @ $4.99 · Option exercise (M): 71,492 @ $7.94 · Option exercise (M): 77,181 @ $8.43 · Option exercise (M): 16,260 @ $14.70 · Sale (S): 11,483 @ $32.64 · Sale (S): 210,468 @ $33.56 · +4 more | EDGAR |
| 2026-04-09 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 13,880 @ $0 · Grant/award (A): 7,061 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 19,351 @ $23.14 · Sale (S): 2,898 @ $23.95 | EDGAR |
| 2025-04-03 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 16,188 @ $0 · Grant/award (A): 7,600 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 6,616 @ $19.52 · Sale (S): 1,384 @ $19.96 | EDGAR |
| 2024-04-04 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 11,255 @ $0 · Grant/award (A): 4,690 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1341896 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →